Novel anti-fibrotic properties of heme binding proteins including Neuroglobin, Myoglobin, and Hemoglobin in comparison with Cytoglobin in vitro and in vivo
Publication acknowledgement; not a spending or impact claim.
Funding acknowledgements in longevity research
Where is longevity research funding appearing?
Explore publicly disclosed funders and award identifiers connected to indexed longevity research, topics, and universities, with links to the original source records.
Checking source-linked funding records…
Index
Explore all topics
Tracked topics
Source-linked comparison
Put two evidence landscapes side by side.
Compare what the index currently contains—not which intervention is “best.” Counts describe source-linked coverage and study maturity; they do not establish benefit, safety, or suitability for any person.
Choose two different topics. You can share the resulting comparison URL.
Current indexed landscape
Evidence comparison
180-topic evidence map
Choose a topic. See how far the evidence goes.
Explore published research, studies involving people, and clinical trials. An empty layer means we have no matching record in this snapshot—not that no evidence exists anywhere.
Questions worth opening
The most useful gaps are relationships between evidence layers.
These are discovery cohorts, not scientific verdicts. Select one to inspect the exact topics and records behind it.
How this topic changed
Open the full change log
Evidence timeline
A source-linked history of new records, trial changes, official notices, corrections, and retractions. This shows movement in the evidence—not whether a treatment works.
Research updates
View research feed
New research records
Funding Radar
Follow grants and disclosed funding behind longevity research.
Browse all funder profiles →Direct grant records from official funder databases are shown separately from award acknowledgements found on publications. This makes the provenance—and the meaning—of every record clear.
Publication-year view
Award-linked research over time
Leading funders
Leading topics
Direct award data
Grants reported by official funder databases
Publication acknowledgements
Awards connected to indexed longevity publications
These records indicate that a publication named a funder or award. They do not establish the full grant value, duration, or scope.
The molecular mechanism of the inhibitory effect of liver cancer development via inter-organ relationship by regular exercise: its application to cancer prevention
Publication acknowledgement; not a spending or impact claim.
Are activated stellate cells producing Cytoglobin directly involved in hepatocarcinogenesis?
Publication acknowledgement; not a spending or impact claim.
Source-linked funding acknowledgement
Publication acknowledgement; not a spending or impact claim.
Analysis of cytokines involved in induction of inflammation associated with disruption of epithelial barrier
Publication acknowledgement; not a spending or impact claim.
Source-linked funding acknowledgement
Publication acknowledgement; not a spending or impact claim.
Inhibitory mechanism of obesity-induced hepatocellular carcinoma by the novel fatty acid metabolized by intestinal microbiota
Publication acknowledgement; not a spending or impact claim.
Search for new therapeutic targets for obesity-induced liver cancer focusing on mRNA degradation regulation
Publication acknowledgement; not a spending or impact claim.
Clinical studies
View all trials
Trial Radar
Trial transparency
Follow the distance between trial completion and visible results.
This monitor checks completed longevity trial registrations. A possible gap means the indexed registry record shows no posted results more than 12 months after its listed completion date. It is a discovery signal—not proof that results are legally overdue, unpublished everywhere, or withheld.
Completion-year view
How visible results vary across completed trial cohorts
Official notices
Research integrity feed
Latest regulatory updates
Live notices appear here only after they pass the automated relevance checks. The official-source library below remains available at all times, so you can verify approvals, safety alerts, recalls, shortages, and product information directly with authorities worldwide.
Global official-source library
Regulatory guides by country and region
Each guide explains where to look, what the authority covers, and what its decisions do—and do not—mean. Every card links to the authority itself.
Corrections & retractions
Research feed
Research integrity
Browse the evidence
Snapshot figures include separate links to current records
Evidence by topic
Each row is one tracked longevity topic. Counts show indexed source relationships—not proof that an intervention works—and a record may belong to more than one topic.
Evidence directory
Built automatically from source recordsPeople, organisations, and topics
Browse by region
Universities active in longevity research.
Select a region to filter the complete ranking. Activity counts source-matched work and topic breadth; it does not rank research quality.
Download the indexSide-by-side
Compare selected universities
Coverage by region
Choose a region, then a country
Each card shows exactly how many official sources and countries are represented. Select one to filter the directory.
All checks run automatically. Match confidence estimates topic relevance; it does not rate safety or effectiveness. No scientist, clinician, editor, or human reviewer approves individual records before publication. See how records are checked.
Sources
Where this information comes from
Loading current evidence…
The intelligence feed is temporarily unavailable.
No uncited fallback content has been substituted. Please try again shortly.